Company Shares of TransEnterix (NYSEMKT:TRXC) Rally 0.79%

TransEnterix (NYSEMKT:TRXC) : During the past 4 weeks, traders have been relatively bearish on TransEnterix (NYSEMKT:TRXC), hence the stock is down -13.81% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.48% relative to the S&P 500. The stock has risen by 0.79% in the past week indicating that the buyers are active at lower levels, but the stock is down -12.41% in the past 4 weeks.

The company shares have dropped -57.53% from its 1 Year high price. On Apr 6, 2016, the shares registered one year high at $6.10 and the one year low was seen on Jun 27, 2016. The 50-Day Moving Average price is $1.51 and the 200 Day Moving Average price is recorded at $2.76.

The stock has recorded a 20-day Moving Average of 4.3% and the 50-Day Moving Average is 21.16%.


TransEnterix (NYSEMKT:TRXC): stock turned positive on Friday. Though the stock opened at $1.17, the bulls momentum made the stock top out at $1.28 level for the day. The stock recorded a low of $1.17 and closed the trading day at $1.27, in the green by 7.63%. The total traded volume for the day was 648,328. The stock had closed at $1.18 in the previous days trading.

In an insider trading activity, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (Chief Technology Officer) of Transenterix Inc., Fernando Anthony C. J., had purchased 27,000 shares in a transaction dated on June 14, 2016. The transaction was executed at $1.46 per share with total amount equaling $39,420.

TransEnterix, Inc. is a medical device company focused on the development and commercialization of a robotic assisted surgical system called the SurgiBot System (the SurgiBot System). The Companys SurgiBot System is designed to utilize flexible instruments through articulating channels controlled directly by the surgeon with robotic assistance while the surgeon remains patientside within the sterile field. It has commercialized the SPIDER Surgical System, (the SPIDER System) a manual laparoscopic system in the United States, Europe and the Middle East. The SPIDER System utilizes flexible instruments and articulating channels that are controlled directly by the surgeon, allowing for multiple instruments to be introduced through a single site. It also offers Flex Ligating Shears (FLS) which is an energy device used with the existing SPIDER Surgical System. The FLS device is designed to deliver controlled energy to ligate and divide tissue.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.